Toronto-based Cybin is set to acquire London-based Small Pharma in an all-share transaction, according to an announcement by Cybin this morning. Small Pharma shareholders will receive 0.2409 Cybin shares for each share of Small Pharma, implying approximately $0.10 per Small Pharma share: a price the company’s stock hasn’t seen since last winter. When all is said and done…


Previous articlePT435 – The Federal Right to Try Act, The Farm Bill, and the Constant Balance Between Risk and Regulation
Next articlePT436 – The Power of Sound: The Magic in Live Performances, Imperfections, and Music Curated Specifically for Journeys